Upper Gastrointestinal Bleeding

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 24

Upper Gastrointestinal Bleeding

27 may 2009

Sathaporn Kunnathum M.D.


Overview
• Cause of Gastrointestinal bleeding
• Clinical Presentation
• Evaluation
• Treatment
Introduction
• Causes depend on site
– UGI = proximal to ligament of Treitz
– LGI = distal to ligament of Treitz
Causes of Significant GI Bleeding
Upper Percentage Lower Percentage
Peptic ulcer dz 45 Diverticulosis 18-43

Gastric Angiodysplasia 20-40


erosions 23
Unknown 11-32
Varices 10
Cancer/polyps 9-33
Mallory-Weiss 7
Rectal disease 8-9
Esophagitis 6
IBD 1-7
Duodenitis 6
Clinical Presentation
• Most common = hematemesis, melena,
hematochezia or black stools
– Hematemesis associated with bleeding
proximal to lig of treitz
– Melena usually proximal to jejunum with
greater than 4 hrs transit time
• requires blood 50-100 mL
Clinical Presentation
– Hematochezia usually due to colonic source
BUT UGIB > 1000 mL and less than 4 hours
transit may be red or maroon
• UGIB: 71% have melena, 56%
hematemesis, 21% maroon stool
Evaluation
• First priority is ABCs
• Intubation occasionally necessary for
overwhelming UGIB
• Aggressive fluid resuscitate if hemodynamic
unstable = Mandatory to have 2 Large Bore I.V.
or central access
• While stabilizing, get initial history, place on
monitor and start O2
Evaluation
• History:
– Duration, quantity, color of blood, associated
symptoms ,precipitating factor, history of GIB, alcohol,
drugs use, underlying disease
Evaluation
• Physical Exam
Vital signs
– PR, BP, RR
– Hypothermia with significant volume depletion
Others
– General appearance: pale?jaundice? conscious?
– Skin: turgor, capillary refill, petechiae/purpura
– Lungs/Heart
– Abdominal exam
– PR
Evaluation
• Laboratory
– Hct
– CBC,plt
– PT/PTT for correctable coagulopathy
– Cross match
– Blood chemistry for azotemia/ARF/Acidosis
– LFT
– ABG if indicated
Treatment
• NPO
• Always start with ABCs
• O2
• 2 Large bore IVs
• Monitor
• NG tube
• Foley cath
• ET tube ?
Treatment
• NG lavage
– Essential to differentiate UGI vs. LGI
– 10-15% of pts with hematochezia have UGIB
Treatment
• NG lavage, cont.
– 79% sensitive for ACTIVE UGIB
– Useful to assess for ongoing hemorrhage
– Not therapeutic
– Not harmful in varices or MW tear
Treatment
• NG lavage, additional notes
– Must confirm placement of tube prior to
lavage
– Sterile lavage fluid not necessary
– Lavage until clear
Treatment
• Fluid resuscitation
– Crystalloid initially
– PRC,Fresh whole blood, FFP, plt conc
• Critical to monitor
Treatment

• Coagulation Defects - consider FFP, Vit K


• Thrombocytopenic (<50,000 and
bleeding) transfuse platelets
• For severe bleeds - consult GI early as
well as general surgery
Treatment
• Additional options
– Empiric acid-suppressive therapy : PPI and
H2 receptor antagonist
– Octreotide - Besson in NEJM 1995 showed
decreased rebleeding in varices after
Octreotide - no change in mortality, however
(50 mcg bolus, then 25-50/hr)
Treatment
• Sengstaken-Blakemore Tube
– Generally not used except in dire circumstance
– High rate of complications and death (14%, 3%)
including aspiration, esophageal and gastric rupture,
mucosal and nasal necrosis
– Attempt only after failure of Octreotide as a bridge to
endoscopy in pts exsanguinating from known varices
– Need to be intubated prior to placement
Treatment
• Endoscopy
– Most accurate tool for evaluating source of
bleeding
– Not usually necessary in first 12 hrs
• no increase in diagnostic accuracy if done earlier
– May be necessary if bleeding is ongoing,
unresponsive to resuscitation or recurrent to
dictate therapy
• Intervention angiography
Treatment
• Surgery
– 15-34% of patients with GIB require surgery
– Mortality for emergency surgery is 23%
• Thank you for your attention

You might also like